Company cites cosmetic differences in corticosteroids

Nemec, John
January 1999
Dermatology Times;Jan1999, Vol. 20 Issue 1, p49
Trade Publication
Focuses on the need for dermatologists to look into cosmetic considerations when selecting topical corticosteroids for inflammatory skin disease patients according to Rukmini Rajagopalan, associated director of biostatics and health economics at Glaxo Wellcome Inc. Results of physician preference testing; Side effects.


Related Articles

  • Fluticasone Topical.  // AHFS Consumer Medication Information;Sep2020, p1 

    Fluticasone, a corticosteroid, is used to reduce inflammation and relieve itching, redness, dryness, and scaling associated with various skin disorders. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

  • Topical corticosteroids aren't always the answer to pruritus.  // Modern Medicine;Sep94, Vol. 62 Issue 9, p23 

    Reports on the limited benefits offered by topical corticosteroids in the treatment of non-inflammatory dermatoses in the United States, according to Dr. Alan B. Fleischer from the Bowman Gray School of Medicine in Winston-Salem, North Carolina. Athrophogenic potential of topical...

  • Topical Corticosteroid Treatment Safe for Children. Guttman, Cheryl // Dermatology Times;Apr2000, Vol. 21 Issue 4, p19 

    Reports on the use of topical corticosteroids in controlling the inflammatory skin response in children with atopic dermatitis. Age and dosage of treatment; Risks associated with topical corticosteroids.

  • Thyroid hormone analogue benefits steroid-induced cutaneous atrophy. Moyer, Paula // Dermatology Times;Oct2002, Vol. 23 Issue 10, p20 

    Reports that using a thyroid hormone analogue relieves cutaneous atrophy associated with the use of topical corticosteroid according to the research of dermatologist, Jan Faergemann. Conflict in the data regarding the efficacy of thyroid hormone; Calculation of median concentrations.

  • Prednicarbate: A Review of its Pharmacological Properties and Therapeutic Use in the Treatment of Dermatological Disorders. Spencer, C.M.; Wagstaff, A.J. // BioDrugs;1998, Vol. 9 Issue 1, p61 

    Prednicarbate is a synthetic nonhalogenated moderate to high potency corticosteroid. It is rapidly metabolised during skin permeation to prednisolone. Prednicarbate is indicated for relief of inflammation and pruritus associated with corticosteroid-responsive dermatological disorders such as...

  • Mid-potency topical corticosteroid for dermatoses.  // Modern Medicine;Mar94, Vol. 62 Issue 3, p25 

    Reports that the mid-potency topical corticosteroid prednicarbate emollient cream has been approved for relieving the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Application of the cream; Side-effects.

  • Greece grease. Newnham, David // Nursing Standard;4/18/2012, Vol. 26 Issue 33, p27 

    David Newnham needs some more magic ointment.

  • EDITORIAL MESSAGE. Del Rosso, James Q.; Werschler, Philip // Journal of Clinical & Aesthetic Dermatology;Nov2013, Vol. 6 Issue 11, p12 

    An introduction is presented in which the editor discusses various reports within the issue on topics including corticosteroid, triamcinolone acetonide aerosol and cream in eczematous dermatoses.

  • Don't delay corticosteroid inhalation therapy for asthmatics.  // Modern Medicine;Nov96, Vol. 64 Issue 11, p56 

    Presents an abstract of the study `Is Delayed Introduction of Inhaled Corticosteroids Harmful in Patients With Obstructive Airways Disease (asthma and COPD)?,' by S.E. Overbeek, H.A.M. Kerstjens, J.M. Bogaard et al and published in the July 1996 issue of the periodical `Chest.'


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics